Product Information
TESTOSTERONE CYP 1,000 MG/10 ML is a generic product labeled by Hospira Inc., priced at $4.5281 per ML under NDC 00409655701. Its NADAC has been published 509 times since Sep 21, 2016.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Hospira Inc.NDC
00409655701
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE CYPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA085635FDA Approved
Before 1982
TE Code
AO
On Market Since
8/1/2016
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE CYP 1,000 MG/10 ML has been published 509 times since Sep 21, 2016, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5281 per ML |
|---|---|
| All-time high | $5.7363 (Nov 13, 2024) |
| All-time low | $3.3677 (May 22, 2024) |
| 52-week high | $5.6425 |
| 52-week low | $4.5281 |
| Median price | $4.1704 |
| Average price | $4.3269 |
| Largest weekly change | +47.1% (Jun 19, 2024) |
| Weeks tracked | 509 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone cypionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE CYP 1,000 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE CYP 1,000 MG/10 ML, manufactured by Hospira Inc., is $4.5281 per ML (NDC 00409655701), effective Sep 30, 2026.
How has the price of TESTOSTERONE CYP 1,000 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE CYP 1,000 MG/10 ML has declined 10.9%. It has been tracked across 509 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE CYP 1,000 MG/10 ML?
Since Sep 21, 2016, the NADAC for TESTOSTERONE CYP 1,000 MG/10 ML has ranged from a low of $3.3677 (May 22, 2024) to a high of $5.7363 (Nov 13, 2024), with a median of $4.1704 per ML.
Are there cheaper alternatives to TESTOSTERONE CYP 1,000 MG/10 ML?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TESTOSTERONE CYP 1,000 MG/10 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures TESTOSTERONE CYP 1,000 MG/10 ML?
TESTOSTERONE CYP 1,000 MG/10 ML (NDC 00409655701) is labeled by Hospira Inc., and CMS classifies it as a generic product.